Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Respiratory Tract Diseases × sintilimab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 10 Stomach Neoplasms 8 Carcinoma, Non-Small-Cell Lung 5 Pancreatic Neoplasms 3 Esophageal Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Thyroid Neoplasms 1 Solid Tumor 1 Recurrence 1 Pancreatic Cancer Resectable 1 Pancreatic Cancer Metastatic 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1 Lung Squamous Cell Carcinoma 1 Locally Recurrent Rectal Cancer 1 Locally Advanced Rectal Cancer (LARC) 1 Locally Advanced Rectal Cancer 1 Localized Advanced Rectal Adenocarcinoma 1 Liver Neoplasms 1 Hemangiosarcoma 1 Gastric Adenocarcinoma 1

Interventions

pembrolizumab 3 Carboplatin 3 selpercatinib 2 pralsetinib 2 durvalumab 2 Pemetrexed 2 Cisplatin 2 taletrectinib 1 sotorasib 1 repotrectinib 1 ceralasertib 1 Telescopes 1 Radiosurgery 1 Paclitaxel 1 Gemcitabine 1 Gefitinib 1 Erlotinib Hydrochloride 1 Bevacizumab 1 AZD3759 1 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡